Trial Profile
A study evaluating clinical outcomes of the oral suspension versus delayed release tablet formulations of posaconazole for prophylaxis of invasive fungal infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2018
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Mycoses
- Focus Therapeutic Use
- 16 Jul 2018 Results published in the Antimicrobial Agents and Chemotherapy
- 23 Oct 2017 New trial record
- 08 Oct 2017 Results presented at the IDWeek 2017